Finasteride
Potent, specific and competitive inhibitor of type II 5alpha-reductase (enzyme which converts testosterone to the more potent 5alpha-dihydrotestosterone). Anticancer compound. Apoptosis modulator. Enhances the action of GABA at GABA(A) receptors, which leads to neurological implications. Inhibit testosterone-induced type I procollagen and TGF-beta1 expression in human scalp dermal fibroblasts in a model of androgenic alopecia. Drug for the treatment of male androgenetic alopecia. Potential role in neuropsychiatric disorders.
| Catalog Number | AG-CR1-3589-M100 |
| Alternative Name(s) | MK 906; L-652,931; BRN 4269024 |
| Research Area | Biochemicals, Cancer, Natural Products, Neurobiology |
| Molecular Formula | C23H36N2O2 |
| CAS# | 98319-26-7 |
| Purity | >98% |
| Inchi | InChI=1S/C23H36N2O2/c1-21(2,3)25-20(27)17-8-7-15-14-6-9-18-23(5,13-11-19(26)24-18)16(14)10-12-22(15,17)4/h11,13-18H,6-10,12H2,1-5H3,(H,24,26)(H,25,27)/t14-,15-,16-,17+,18+,22-,23+/m0/s1 |
| Inchi Key | DBEPLOCGEIEOCV-WSBQPABSSA-N |
| SMILES | [H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C |
| Size | 100 mg |
| Supplier Page | http://www.adipogen.com/ag-cr1-3589/finasteride.html |